Amazon Drugs Private Limited
About Amazon Drugs Private Limited
Data last updated:
Amazon Drugs Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 01 September 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U02423KA1987PTC008556. Its GSTIN is 29AABCA4370K1ZJ (Karnataka).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹29.96 Lakh. It is led by directors Tej Sadhu Krishen (Managing Director) and Deepak Sadhu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.9 Old No. 57 / 3 – 21 19th Cross 7th Main Btm Layout 2nd Stage, Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.9 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹2.65 Lakh (net margin 3.9%) and EBITDA of ₹3.93 Lakh (EBITDA margin 5.7%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 16% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹68 Lakh on record. Court records list 28 cases involving the company, including 25 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.9 Old No. 57 / 3 – 21 19th Cross 7th Main Btm Layout 2nd Stage, Bangalore, Karnataka, India – 560076
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Amazon Drugs Private Limited
The main business activity of Amazon Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amazon Drugs Private Limited FY 2025 filings available
Amazon Drugs Private Limited reported revenue of ₹68.9 Lakh (down 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Amazon Drugs Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 24% fall in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amazon Drugs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.65 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amazon Drugs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amazon Drugs are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Amazon Drugs Private Limited
Amazon Drugs Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Majestic Enterprises Private Limited | ₹69.08 Lakh (FY 2015) | •••• | •••• | -24.0% | •••• | Chennai, Tamil Nadu, India |
| Yuj Fiberchem Private Limited | ₹69.04 Lakh (FY 2025) | •••• | •••• | -57.0% | •••• | Thane, Maharashtra, India |
| Qview Life Sciences Private Limited | ₹68.99 Lakh (FY 2025) | •••• | •••• | 464.0% | •••• | Hyderabad, Telangana, India |
| Chlora Aceso Pharmaceuticals Private Limited | ₹68.97 Lakh (FY 2024) | •••• | •••• | 73.0% | •••• | Prayagraj, Uttar Pradesh, India |
| Seaside Salt Private Limited | ₹68.93 Lakh (FY 2024) | •••• | •••• | -80.0% | •••• | Gandhidham, Gujarat, India |
| Amazon Drugs Private Limited this company | ₹68.9 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Bangalore, Karnataka, India |
| Sunhill Healthcare Private Limited | ₹68.74 Lakh (FY 2025) | •••• | •••• | -61.0% | •••• | Delhi, India |
| Zenobia Pharmaceuticals Private Limited | ₹68.72 Lakh (FY 2021) | •••• | •••• | -42.0% | •••• | Kozhikode, Kerala, India |
| Amnour Pharmaceuticals Private Limited | ₹68.69 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Pune, Maharashtra, India |
| Fledge Healthcare Private Limited | ₹68.65 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Chandrapur, Maharashtra, India |
| Alvizia Healthcare Private Limited | ₹68.64 Lakh (FY 2025) | •••• | •••• | 107556.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Amazon Drugs by revenue in the Chemicals industry (Formulations, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amazon Drugs Private Limited
Amazon Drugs Private Limited is audited by SAINATH & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAINATH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Amazon Drugs Private Limited
Amazon Drugs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Sadhu Also directs: Trayamesha Services LLP, Lexhelix LLP | Director | 22 Mar 2013 | 13 Years 6 Months | Current |
| Tej Sadhu Krishen | Managing Director | 03 Sep 1987 | 39 Years 1 Months | Current |
Ownership and Shareholding of Amazon Drugs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amazon Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2006 | State Bank of Mysore | ₹35 Lakh | Open |
| 28 Mar 1994 | Jammu & Kashmir Bank Ltd. | ₹9 Lakh | Open |
| 07 Sep 1992 | M/S Karnataka State Financial Corporation | ₹24 Lakh | Open |
Total charge records: 3 View all charges
Legal Cases of Amazon Drugs Private Limited
Amazon Drugs Private Limited has 28 court cases on record: 25 filed by Amazon Drugs, 3 filed against it. 1 case is pending and 27 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 3 | 0 |
| High courts | 6 | 0 | 1 |
Cases on record (5 of 28)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against Union of India | Pending |
| District court, Ranchi, Jharkhand | Appeal | Filed by the company against P.N.H.Pharmaceuticals | Disposed |
| High Court of Karnataka | Appeal | Filed by the company against an individual | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Disposed |
| District court, KOPPAL, Karnataka | Criminal complaint | Filed by the company against an individual | Disposed |
Full case history
All 28 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Amazon Drugs Private Limited
Amazon Drugs Private Limited has a workforce of 2 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amazon Drugs Private Limited
Amazon Drugs Private Limited has 6 board changes on record since 1987: 2 appointments and 4 cessations. The latest: Sarla Sadhu ceased to be Director on 12 Jun 2013.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Amazon Drugs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amazon Drugs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amazon Drugs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amazon Drugs Private Limited
Amazon Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCA4370K1ZJ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amazon Drugs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amazon Drugs Private Limited
Amazon Drugs is an active private limited company based in Bangalore, Karnataka, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 01 September 1987 (39+ years old) and is registered under CIN U02423KA1987PTC008556.
Amazon Drugs reported revenue of ₹68.9 Lakh for FY 2025 (down 24% YoY).
Amazon Drugs has 2 current directors:
- Tej Sadhu Krishen - Managing Director
- Deepak Sadhu - Director
Amazon Drugs reported a net profit of ₹2.65 Lakh (net margin 3.9%) and EBITDA of ₹3.93 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Amazon Drugs is -22% over three years and -16% over five years. In the latest year (FY 2025) revenue fell 24%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Amazon Drugs is 29AABCA4370K1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Amazon Drugs is U02423KA1987PTC008556. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amazon Drugs has 28 court cases on record: 25 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Amazon Drugs was incorporated on 01 September 1987, making it 39+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Amazon Drugs by revenue are Majestic Enterprises Private Limited, Yuj Fiberchem Private Limited, Qview Life Sciences Private Limited, Chlora Aceso Pharmaceuticals Private Limited, Seaside Salt Private Limited and 5 more, all in the Chemicals industry (Formulations, Industrial Chemicals).
Sarla Sadhu ceased to be Director on 12 Jun 2013. Deepak Sadhu was appointed as Director on 22 Mar 2013. Phool Chand Juharmal ceased to be Director on 18 Jan 2010. Amazon Drugs has 6 board changes on record in total.